Duke study finds combo treatment can extend lives of prostate cancer patients

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research done at Duke.
Source: WRAL News